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Abstract
Introduction: Lipopolysaccharide (LPS) stimulates the synthesis and release of reactive oxygen species that play an impor-
tant role in the pathogenesis of tissue injuries. In this study the effect of early administration of the antioxidant α-lipoic acid
(α-LA) on brain lipid peroxidation, brain hydrogen peroxide (H2O2) concentration, and brain total sulfhydryl group (-SH
group) content was evaluated in rats with endotoxic shock induced by administration of LPS (Escherichia coli 026:B6, 30
mg/kg i.v.) 
Materials and Methods: Rats were treated intravenously with normal saline or α-LA (60 mg/kg) 30 min after LPS injection.
After 5 h of observation, the animals were killed and their brains were isolated for the measurements. 
Results: Injection of LPS alone resulted in the development of shock and oxidative stress, the latter indicated by a signifi-
cant increase in brain concentrations of thiobarbituric acid-reacting substances (TBARS) and H2O2 and a decrease in total
brain -SH group content. Administration of α-LA after the LPS challenge resulted in an increase in total -SH group content
and a decrease in TBARS and H2O2 concentration in the brain tissue compared with the LPS group.
Conclusion: The results indicate that α-LA treatment effectively protected the brain tissue against endotoxin-induced oxida-
tive stress. Administration of LA could be a useful adjunct to clinical application in the management of septic shock.
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INTRODUCTION
Lipopolysaccharide (endotoxin; LPS) is a major com-
ponent of the outer membrane of Gram-negative bacte-
ria and is responsible for the initiation of the host
response to the microorganisms. The first phagocytic cells
that come into contact with the LPS are macrophages and
neutrophils. In response to LPS, macrophages secrete
proinflammatory cytokines such as tumor necrosis factor
(TNF)-α, the interleukins IL-6, IL-1β, and IL-12 (Kagan
et al. 1992; Panigrahi et al. 1996; Rankine et al. 2006),
free radicals, and reactive oxygen species (ROS), such as
superoxide anion (Minuz et al 2006; Victor et al 2003).
An excess of ROS may cause cell death by oxidizing pro-
teins, DNA damage, or lipid peroxidation of cellular
membranes (Floyd et al. 2001; Laskin and Pendino 1995).
It is well documented that proinflammatory cytokines
and ROS contribute to the development of septic shock,
multiple organ failure, and death. 
Brain tissue is highly susceptible to oxidative injury
compared with other tissues (Halliwell 2006). The vul-
nerability of the brain to oxidative damage is probably
due to membrane phospholipids rich in polyunsaturated
fatty acids, which are a source of peroxidation, a high
consumption of oxygen and a low quantity of enzymes
mopping up ROS, and neurons’ inability to multiply. As
the capacity of the endogenous antioxidative system of
brain tissue is limited, antioxidants such as LA could
protect neural tissue from being damaged by increased
ROS.
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DL-α-lipoic acid (LA, DL-6,8-dithiooctanoic acid)
is an endogenous thiol antioxidant that has the poten-
tial to quench ROS, regenerate glutathione (GSH),
and chelate metals such as iron, copper, mercury, and
cadmium, which are known to mediate free-radical
damage in biological systems (Akpinar et al. 2007;
Applegate et al. 2008; Bilska and W³odek 2005;
Savitha et al. 2005; Skibska et al. 2006). As LA is well
soluble not only in water, but in fats as well, and is a
small molecule (molecular weight: 206), it may easily
cross the blood-brain barrier and stabilize it (Cakatay
2006; Roy and Packer 1998; Roy et al. 1997; Schreibelt
et al. 2006). 
In most of the experiments performed by other
authors, LA was administered before oxidative stress
was observed. The present study was undertaken to
investigate whether LA affects the level of lipid peroxi-
dation, hydrogen peroxide (H2O2) concentration, and
the content of sulfhydryl groups (-SH groups) in the
brains of endotoxin-pretreated male rats.
MATERIALS AND METHODS
Chemicals
Lipopolysaccharide (Escherichia coli LPS 026:B6,
lyophilized powder chromatographically purified by gel
filtration, protein content <1%),  α-LA, thiobarbituric
acid (TBA), butylated hydroxytoluene (BHT), and sodi-
um acetate trihydrate were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). All other reagents
were obtained from POCh (Gliwice, Poland) and were
of analytical grade. Shortly before use, the LPS was dis-
solved in sterile pyrogen-free normal saline. α-LA was
mixed with sterile normal saline in a dark bottle and
NaOH was added until the suspension was dissolved.
The pH was then brought to 7.4 with HCl. TBA solution
was prepared by dissolving 0.67 g of TBA in 100 ml of
de-ionized water and then diluted 1:1 with glacial acetic
acid. Sterile, de-ionized water (resistance >18 MΩ-cm,
HPLC Water Purification System USF ELGA,
England) was used throughout the study.
Animals
The experiments were performed on 52 adult male
Wistar rats weighing 260–300 g. The animals were
housed six rats per cage under standard laboratory con-
ditions, with a 12/12 h light-dark cycle (light on at 7:00
a.m.), an ambient temperature of 20±2ºC, and humidity
of 55±5%. All the animals received a standard laboratory
diet and water ad libitum. All the animals were given 
a one-week acclimation period before the start of the
experiment. The experimental procedures followed the
guidelines for the care and use of laboratory animals and
were approved by the Medical University of £ódŸ Ethics
Committee.
Experimental design
The animals were randomly divided into five groups.
Group I (n=10, NaCl/NaCl control rats) received 0.2 ml
saline twice, 0.5 h apart. Group II (n=10, NaCl/LA60
group) served as LA controls; the animals received 0.2
ml saline and were injected 0.5 h later with a single dose
(60 mg/kg b.w.) of DL-α-LA. Group III (n=10,
NaCl/LA100 group) received 0.2 ml saline and were
injected with a single dose (100 mg/kg) of DL-α-LA 0.5
h later. Group IV (n=12, with 2 dead animals during the
experiment, NaCl/LPS group) served as LPS controls;
the rats were given 0.2 ml saline and endotoxic shock
was induced 0.5 h later by an injection of E. coli LPS at
a concentration of 30 mg/kg. Group V (n=10,
LPS/LA60 group) received a single dose of LPS (0.2 ml,
30 mg/kg) and a single dose of LA (60 mg/kg) after 0.5
h. Group VI (n=10, LPS/LA100 group) received a sin-
gle dose of LPS (0.2 ml, 30 mg/kg) and a single dose of
LA (100 mg/kg) after 0.5 h. 
All agents were injected intravenously into the tail
vein between 8:00 and 9:00 a.m.. The rat’s body temper-
ature was taken in the rectum with a thermistor ther-
mometer (type PU 319/1, Czechoslovakia) before the
first injection and then 1, 2, 3, and 5 h later. After 5 h of
observation, the animals were anesthetized with pento-
barbital (50 mg/kg i.p.). 
Brain homogenates
The skulls were split on an ice and salt mixture and
the whole brain of each rat was extracted, weighed, and
homogenized in either 1.15% KCl for the assay of TBA
reactive substance (TBARS) and H2O2 concentration or
in 6% trichloroacetic acid (TCA) for determination of
the content of free -SH groups.
Determination of lipid peroxidation
The content of lipid peroxidation products in the
brain homogenates was assayed as TBARS. Briefly, 4 ml
of 0.25% hydrochloric acid containing 0.375% TBA,
15% TCA, and 0.015% BHT was added to 2 ml of the
brain homogenate. The samples were boiled for 30 min
at 100°C in tightly closed tubes. After cooling to 10°C, 2.5
ml of butanol was added to each tube and, after intensive
shaking, the tubes were centrifuged for 10 min (3800 rpm,
20°C). TBARS in the butanol layer were measured spectro-
fluorometrically using a Perkin Elmer LS-50 Luminescence
Spectrometer (Norwalk, CT, USA). Excitation was set at
515 nm and emission was measured at 546 nm. The read-
ings were converted into µM by the regression equation
Y = 0.39 × (X – Xo) – 1.32, 
where Y – µmol/l TBARS and X and Xo the fluorescence
intensities of the sample and control, respectively, in arbi-
trary units (arbitrary units, AU). The regression equation
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with six increasing concentrations of tetramethoxypropane
as a standard of TBARS (0.01–50 µM). A mixture of 2 ml
of 1.15% potassium chloride and 4 ml of 0.25 N hydrochlo-
ric acid was used as a control. Finally, the results were cal-
culated for 50 mg of brain tissue.
Determination of H2O2
H2O2 generation in the brain homogenates was
determined according to the Ruch et al. method (Ruch
et al. 1983) with some modifications. Briefly, a 10-µl
aliquot of tissue homogenate was mixed with (i) 90 µl of
phosphate-buffered saline (PBS, pH 7) and 100 µl of
horseradish peroxidase (1 U/ml) containing 400 µmol
homovanilic acid (HRP+HVA assay) or (ii) 90 µl of
PBS and 100 µl of 1 U/ml horseradish peroxidase only
(HRP assay). Both homogenates were incubated for 60
min at 37°C. Then 300 µl of PBS and 125 µl of 0.1 M gli-
cyne-NaOH buffer (pH 12.0) with 25 mM EDTA were
added to each homogenate sample. Excitation was set at
312 nm and emission was measured at 420 nm (Perkin
Elmer Luminescence Spectrometer, Beaconsfield, UK).
The readings were converted into H2O2 concentration using
the regression equation 
Y = 0.012 × X – 0.0007, 
where Y is the concentration of H2O2 in the homogenate
(µM) and X the intensity of light emission at 420 nm for the
HRP+HVA assay reduced by the HRP assay emission
(AU). The regression equation was prepared from three
series of calibration experiments with 10 increasing H2O2
concentrations (range: 10–1000 µM). The lower limit of
H2O2 detection was set 0.1 nM, with intra-assay variability
not exceeding 2%. 
Measurement of the total -SH group content 
in brain homogenates
The -SH group content in the tissue homogenates
was determined by the 2.2-dithiobisnitrobenzoic acid
(DTNB) assay described by Ellman (Ellman 1970).
Briefly, 50 mg of the organ sample was thawed and
homogenized with 6% TCA in a 1:20 volume proportion
at 0°C. Then the homogenate was centrifuged for 20 min
(10,000 × g, 4°C). The volume of 0.5 ml of the supernatant
was mixed with 0.5 ml of 0.3 M Na2HPO4 and 0.5 ml of
0.04% Ellman reagent (DTNB) freshly dissolved in 10%
sodium citrate water solution. All the reagents added were
previously cooled to 0°C. The absorbance of the obtained
solution was measured at 412 nm using a Pharmacia LKB-
-Ultrospect III spectrophotometer. The readings were con-
verted into -SH group content (µM) by the regression equation 
Y =  –0.2998 + 241.954 × X, 
where Y is the free -SH group content (µM) and X the
intensity of light emission at 420 nm (AU). The regression
equation was prepared on the basis of three series of cali-
bration experiments in which increasing concentrations of
GSH (2–200 µmol/l) were used. The control assay was car-
ried out with a solution of 0.5 ml of 6% TCA, 0.5 ml of 0.3 M
Na2HPO4 – sodium phosphate, and 0.5 ml of 0.04% DTNB.
Statistical analysis
Data are presented as the mean ±SE from 10 ani-
mals in each group. Statistical significance was evaluat-
ed using the ANOVA test followed by Duncan’s multi-
ple range test as a post hoc test. Differences were con-
sidered significant if p≤0.05.
RESULTS
Body temperature and general behavior
In the control group there was no change in body
temperature throughout the experiment (33.2±0.1°C).
Similarly, infusion of α-LA had no effect on body tem-
perature. Injection of LPS resulted in a body tempera-
ture decline of about 2°C compared with the saline and
Na/LA groups (p<0.001). Some decrease in body tempera-
ture was observed in the LPS/LA60 group, but after 5 h of
Table 1. The effect of lipoic acid on LPS-induced changes in the body temperature in rats
Temperature/ Before 1 h 2 h 3 h 5 h
Group 
of animals
NaCl/NaCl 33.2±0.20 33.2±0.20 33.2±0.20 33.2±0.20 33.2±0.20
NaCl/LA60 33.7±0.20 33.8±0.25 33.7±0.30 33.8±0.20 33.5±0.20
NaCl/LA100 33.5±0.20 33.6±0.20 33.4±0.23 33.3±0.20 33.3±0.15
NaCl/LPS 33.3±0.13 32.0±0.19b 31.6±0.20b 31.5±0.20b 31.5±0.20b
LPS/LA60 33.3±0.15 33.0±0.29 32.2±0.30a 32.2±0.40a 32.6±0.30
LPS/LA100 33.3±0.20 33.2±0.20 33.2±0.20 33.0±0.29 33.1±0.22
LPS (30 mg/kg, i.v.) or 0.2 ml saline were administered into the tail vein and the rats were injected 0.5 h later with LA (60 or 100
mg/kg, i.v.). Body temperature was measured in the rectum before and 1, 2, 3, and 5 h after injections. Mean ±SE, ap<0.001,
bp<0.05 vs. baseline temperature.144  A. Gora  ˛ ca et al: α−Lipoic acid in oxidative stress
observation the body temperature rose to 32.6±0.3°C
(Table 1). In the NaCl/LA100 group, no decrease in body
temperature was observed. Animals challenged with LPS
alone displayed reduced motor activity and adopted a
hunched posture. The changes in animal behavior were vis-
ible within 1 h after LPS injection. In contrast, the behavior
of the animals of the LPS/LA60 and LPS/LA100 groups
was similar to that of the control group. Mortality in the
NaCl/LPS group was about 17%. No animals died in the
control, NaCl/LA60, NaCl/LA100, and LPS/LA groups. 
Changes in brain lipid peroxidation levels
The TBARS level in the brain homogenates after
LPS administration (group IV) was 3.3-fold higher than
in the control group (p<0.001, n=10). The level of
TBARS in the NaCl/LA60 group slightly decreased
(p<0.05) compared with the control group. LA 60
mg/kg administered after LPS challenge (group V) sig-
nificantly suppressed the extent of lipid peroxidation in
the brain homogenates compared with the NaCl/LPS
group (1.49±0.2 vs. 4.37±0.37 µM, p<0.001, n=10).
Similar results were obtained with a 1.5-fold higher dose
of LA (Table 2).
Changes in H2O2 concentration 
The concentration of H2O2 in brain homogenate was
significantly higher in the animals treatment with LPS
than in the controls (0.173±0.013 vs. 0.037±0.006 µM,
p<0.001, n=10). The administration of LA (60 mg/kg
b.w.) after LPS challenge significantly reduced H2O2 con-
centration in the brain homogenates compared with the
LPS group (0.113±0.014 vs. 0.173±0.013 µM, p<0.01,
n=10). LA at a dose of 100 mg/kg b.w. reduced H2O2
concentration in the brain homogenates in the same
range of values as LA at a dose of 60 mg/kg (Table 2).
Content of total -SH groups in the brain 
Rats treated with LPS (group IV) had significantly
(p<0.01) lower -SH groups levels than rats treated with
LA (groups II and III). Administration of LA (60 mg/kg
b.w.) after LPS challenge significantly increased the
content of -SH groups in the brain homogenates com-
pared with the NaCl/LPS group (5.53±0.33 vs.
4.06±0.28  µM, p<0.01, n=10). Similar results were
obtained with the higher dose of LA (100 mg/kg b.w.;
Table 2).
DISCUSSION
These data show that intravenous administration of
LPS causes oxidative brain injury which is manifested by
a significant increase in TBARS and H2O2 concentra-
tion and a decrease in the concentration of -SH groups
in brain homogenates. The increase in lipid peroxida-
tion in this study is a result of increased ROS produc-
tion, which in turn leads to excessive peroxidation of
polyunsaturated fatty acids, causing neuron damage
(Halliwell 2006; Halliwel and Gutteridge 1997; Muthu-
swamy et al. 2006). It was previously reported that LPS,
a potent inducer of inflammation and activator of
macrophages, produces an abundance of ROS in
microglia cells present in the brain (Halliwell 2006). The
neurotoxic effects of LPS on brain neurons are mediat-
ed by the activation of microglial cells, IL-1β, and cas-
pase-11 (Arai et al. 2004). Moreover, the systemic
administration of LPS (experimental model of sepsis)
causes a release of glutamate, aspartate, and taurine in
the central nervous system which in excess cause distur-
bances in calcium homeostasis, leading to the produc-
tion of free radicals (Lin et al. 1999; Packer et al. 1997).
The increased formation of ROS in our study was
indicated by the increased level of H2O2 in the brains of
the LPS-challenged rats. H2O2 is an important compo-
nent of the cascade of events during which ROS are pro-
duced (Halliwell 2006; Panigrahi et al. 1996) and is one
of the most stable toxic oxygen metabolites. It is also
volatile and, due to its lack of charge, easily crosses cell
membranes by simple diffusion. This allows the promo-
tion of radical reactions at a great distance from its ori-
gin. Catalase and GSH peroxidase are basic enzymes
regulating intracellular H2O2 concentration. In the
brain, catalase activity is low and the antioxidant enzyme
superoxide dismutase is localized mainly in neurons
(Delacourte et al. 1988), while GSH peroxidase and
Table 2. The influence of administration of LA on oxidative stress parameters in brain homogenates of rats subjected to LPS-
induced shock 
Parameter Saline LA60 LA100 LPS LPS+LA60 LPS+LA100
TBARS (µM) 1.320±0.022 0.870±0.010b 0.860±0.040b 4.370±0.370a,b 1.490±0.200a,d 1.470±0.028a,c,d
H2O2 (µM) 0.037±0.005 0.039±0.006 0.036±0.004 0.173±0.013a,b 0.113±0.014b,e 0.111±0.013b,c,e
Free-SH 5.310±0.270 5.510±0.300 5.610±0.270 4.060±0.280a,c 5.530±0.330e 5.550±0.290e
groups (µM)
Two doses of LA were used: 60 and 100 mg/kg b.w. Mean ±SE.
All administrations were performed intravenously between 8:00 and 9:00 a.m. ap<0.001 vs. LA60 or LA100, bp<0.001 vs. saline,
cp<0.01 vs. saline, dp<0.001 vs. LPS, ep<0.01 vs. LPS.
Abbreviations: LPS – lipopolysaccharide, LA60 – lipoic acid 60 mg/kg body weight, LA100 – lipoic acid 100 mg/kg; TBARS –
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GSH are mainly in astrocytes (Benzi and Moretti 1995).
A deficit of these enzymes and their localization in the
brain suggest that neural tissue may be especially sus-
ceptible to hydroxyl radicals (Packer et al. 1997). In case
of an inadequate level of enzymes able to degrade H2O2,
more H2O2 can be converted to toxic hydroxyl radical
that could then contribute to oxidative stress.
In this study, the decrease in the content of -SH
groups in the LPS-treated rats may be a result of
decreased activity of GSH reductase (Rankine et al.
2006) and transferase or increased activity of GSH per-
oxidase (Malmezat et al. 2000). A decreased concentra-
tion of tissue GSH and an increase in GSSG concentra-
tion during the initial phase of septic shock was
observed by Tsiotou et al. (Tsiotou et al. 2005).
The present study also showed that LA at a dose of
60 mg/kg is highly effective in reducing free radicals and
lipid peroxidation in the brains of septic rats.
Administration of LA 0.5 h after i.v. LPS injection
caused significant decreases in both TBARS and H2O2
concentrations in brain homogenates. However, more
than a 1.5-fold increase in the dose of LA did not cause
a further reduction in the scale of oxidative brain dam-
age. Moreover, LA administration also resulted in
improved survival rate and less advanced hypothermic
reaction of septic rats compared with untreated animals,
which is in agreement with other reports (Riedel et al.
2003). Panigrahi et al. (Panigrahi et al. 1996) indicated
that the administration of LA to animals subjected to
ischemia-reperfusion (e.g. by occlusion of a cerebral
artery) alleviated the effects of reperfusion, lowered the
level of ROS in the brain cells, reduced an extent of
damage, and prolonged the survival time of the animals
compared with a control group. 
It was also demonstrated in the present study that
early administration of LA after LPS challenge signifi-
cantly increased the brain SH group content. An
increase in -SH group concentration after administra-
tion of both LA doses (60 and 100 mg/kg b.w.) may indi-
cate an enhanced synthesis of proteins containing SH
groups or the synthesis of GSH. It has been demon-
strated that LA increased the de novo synthesis of cellu-
lar GSH by improving cysteine utilization (Han et al.
1997). An increase in GSH concentration may lead to a
higher activity of enzymes involved in GSH synthesis
and a reduction in GSH as well (Malmezat et al. 2000).
GSH maintains the reduced state of -SH groups
required for the proper function of different types of
proteins. For this reason, maintaining intracellular GSH
at an appropriate level is essential for protecting neu-
rons against oxidative stress. In in vivo and in vitro stud-
ies it has been shown that the administration of LA
increased the intracellular GSH level by 30–70% (Han
et al. 1995). Another action of α-LA in brain tissue and
also in the other tissues is connected with its inhibition
of NF-κB and AP-1 (a dimer of c-fos and c-jun proteins)
activity (Minuz et al 2006). Furthermore, LA con-
tributes to other antioxidant systems by enhancing the
effects of coenzyme Q10 and GSH (Savitha et al. 2005)
and also by regenerating other antioxidants, such as vit-
amins C and E (Kagan et al. 1992). All these effects of
LA in LPS-induced sepsis are in accordance with the
findings of LA’s antioxidant properties. Moreover, this
antioxidant can also inhibit acute inflammatory
response in vitro and in vivo by activating the PI3/Akt
pathway (Zhang et al. 2007).
In conclusion, this study suggests that LA limits
damage to nerve tissue and protects it from being
exposed to oxidizing stress even if this antioxidant is
administered 0.5 h after LPS challenge. The effective-
ness of LA’s protective action against endotoxic brain
damage indicated by our experiments could encourage
the clinical use of this compound as a treatment for
endotoxemia.
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